Siddharth Bhatia

694 total citations · 1 hit paper
17 papers, 472 citations indexed

About

Siddharth Bhatia is a scholar working on Genetics, Virology and Surgery. According to data from OpenAlex, Siddharth Bhatia has authored 17 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 8 papers in Virology and 6 papers in Surgery. Recurrent topics in Siddharth Bhatia's work include Venomous Animal Envenomation and Studies (8 papers), Rabies epidemiology and control (8 papers) and Inflammatory Bowel Disease (6 papers). Siddharth Bhatia is often cited by papers focused on Venomous Animal Envenomation and Studies (8 papers), Rabies epidemiology and control (8 papers) and Inflammatory Bowel Disease (6 papers). Siddharth Bhatia collaborates with scholars based in India, United States and Japan. Siddharth Bhatia's co-authors include Maria Rosario, Filip Baert, Silvio Danese, Krisztina Kisfalvi, Séverine Vermeire, Geert D’Haens, William J. Sandborn, Karthikeyan Vasudevan, Xiaopan Yao and Željko Krznarić and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and The American Journal of Gastroenterology.

In The Last Decade

Siddharth Bhatia

16 papers receiving 469 citations

Hit Papers

Efficacy and Safety of Vedolizumab Subcutaneous Formulati... 2019 2026 2021 2023 2019 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy and Safety of Vedolizumab Subcutaneous Formulation in a Randomized Trial of Patients With Ulcerative Colitis
    2019 212 citations William J. Sandborn, Filip Baert et al. Gastroenterology profile →

Peers

Siddharth Bhatia
Emanuelle Bellaguarda United States
Oliver Large United Kingdom
Neil Fraser United Kingdom
J.‐F. Rahier Belgium
Sue P. Irwin Canada
Mathurin Flamant France
Naoki Kasuga Japan
Sophie Tops Belgium
Aurada Cholapranee United States
Brett Loechelt United States
Emanuelle Bellaguarda United States
Siddharth Bhatia
Citations per year, relative to Siddharth Bhatia Siddharth Bhatia (= 1×) peers Emanuelle Bellaguarda

Countries citing papers authored by Siddharth Bhatia

Since Specialization
Citations

This map shows the geographic impact of Siddharth Bhatia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siddharth Bhatia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siddharth Bhatia more than expected).

Fields of papers citing papers by Siddharth Bhatia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siddharth Bhatia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siddharth Bhatia. The network helps show where Siddharth Bhatia may publish in the future.

Co-authorship network of co-authors of Siddharth Bhatia

This figure shows the co-authorship network connecting the top 25 collaborators of Siddharth Bhatia. A scholar is included among the top collaborators of Siddharth Bhatia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siddharth Bhatia. Siddharth Bhatia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bhatia, Siddharth, et al.. (2025). Dissecting Daboia: Investigating synergistic effects of Russell's viper venom toxins. International Journal of Biological Macromolecules. 321(Pt 4). 146533–146533.
2.
Laxme, R. R. Senji, Suyog Khochare, Siddharth Bhatia, Gerard Martin, & Kartik Sunagar. (2024). From birth to bite: the evolutionary ecology of India's medically most important snake venoms. BMC Biology. 22(1). 161–161. 8 indexed citations
3.
Bhatia, Siddharth, et al.. (2024). Elusive elapids: biogeographic venom variation in Indian kraits and its repercussion on snakebite therapy. Frontiers in Pharmacology. 15. 1443073–1443073. 2 indexed citations
4.
Bhatia, Siddharth, et al.. (2023). The Royal Armoury: Venomics and antivenomics of king cobra (Ophiophagus hannah) from the Indian Western Ghats. International Journal of Biological Macromolecules. 253(Pt 2). 126708–126708. 4 indexed citations
5.
Bhatia, Siddharth, Omesh Kumar Bharti, Hmar Tlawmte Lalremsanga, et al.. (2023). Multilevel Comparison of Indian Naja Venoms and Their Cross-Reactivity with Indian Polyvalent Antivenoms. Toxins. 15(4). 258–258. 10 indexed citations
6.
Hirano, Ikuo, Evan S. Dellon, Sandeep K. Gupta, et al.. (2023). Safety of an investigational formulation of budesonide (budesonide oral suspension) for eosinophilic oesophagitis: an integrated safety analysis of six phase 1–3 clinical trials. Alimentary Pharmacology & Therapeutics. 57(10). 1117–1130. 9 indexed citations
7.
Bhatia, Siddharth, et al.. (2022). Evaluating Antivenom Efficacy against Echis carinatus Venoms—Screening for In Vitro Alternatives. Toxins. 14(7). 481–481. 13 indexed citations
8.
Hyams, Jeffrey S., Dan Turner, Stanley A. Cohen, et al.. (2022). Pharmacokinetics, Safety and Efficacy of Intravenous Vedolizumab in Paediatric Patients with Ulcerative Colitis or Crohn’s Disease: Results from the Phase 2 HUBBLE Study. Journal of Crohn s and Colitis. 16(8). 1243–1254. 25 indexed citations
9.
Chung, Hyewon, et al.. (2021). Evaluation of safety and pharmacokinetics of bismuth‐containing quadruple therapy with either vonoprazan or lansoprazole for Helicobacter pylori eradication. British Journal of Clinical Pharmacology. 88(1). 138–144. 33 indexed citations
10.
Bhatia, Siddharth, et al.. (2021). Immunorecognition capacity of Indian polyvalent antivenom against venom toxins from two populations of Echis carinatus. Toxicon. 201. 148–154. 5 indexed citations
11.
Vermeire, Séverine, Geert D’Haens, Filip Baert, et al.. (2021). Efficacy and Safety of Subcutaneous Vedolizumab in Patients With Moderately to Severely Active Crohn’s Disease: Results From the VISIBLE 2 Randomised Trial. Journal of Crohn s and Colitis. 16(1). 27–38. 108 indexed citations
12.
Bhatia, Siddharth & Karthikeyan Vasudevan. (2020). Comparative proteomics of geographically distinct saw-scaled viper (Echis carinatus) venoms from India. SHILAP Revista de lepidopterología. 7. 100048–100048. 29 indexed citations
13.
Danese, Silvio, Krisztina Kisfalvi, Wen‐Wen Zhang, et al.. (2020). S0653 Long-Term Treatment With Vedolizumab SC in Ulcerative Colitis: Interim Results From VISIBLE OLE. The American Journal of Gastroenterology. 115(1). S327–S327. 3 indexed citations
14.
Vermeire, Séverine, Geert D’Haens, Filip J. Baert, et al.. (2020). 950 THE VISIBLE 2 PHASE 3 STUDY OF EFFICACY AND SAFETY OF VEDOLIZUMAB SC FOR MODERATE-TO-SEVERE CROHN'S DISEASE. Gastroenterology. 158(6). S–194. 2 indexed citations
15.
Vermeire, Séverine, William J. Sandborn, Filip Baert, et al.. (2020). OP23 Efficacy and safety of vedolizumab SC in patients with moderately to severely active Crohn’s disease: Results of the VISIBLE 2 study. Journal of Crohn s and Colitis. 14(Supplement_1). S020–S021. 8 indexed citations
16.
Sandborn, William J., Filip Baert, Silvio Danese, et al.. (2019). Efficacy and Safety of Vedolizumab Subcutaneous Formulation in a Randomized Trial of Patients With Ulcerative Colitis. Gastroenterology. 158(3). 562–572.e12. 212 indexed citations breakdown →
17.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emanuelle Bellaguarda Breakdown of academic impact, for papers by Oliver Large Breakdown of academic impact, for papers by Neil Fraser Breakdown of academic impact, for papers by J.‐F. Rahier Breakdown of academic impact, for papers by Sue P. Irwin Breakdown of academic impact, for papers by Mathurin Flamant Breakdown of academic impact, for papers by Naoki Kasuga Breakdown of academic impact, for papers by Sophie Tops Breakdown of academic impact, for papers by Aurada Cholapranee Breakdown of academic impact, for papers by Brett Loechelt
Rankless by CCL
2026